Market revenue in 2024 | USD 838.8 million |
Market revenue in 2030 | USD 1,255.1 million |
Growth rate | 6.8% (CAGR from 2025 to 2030) |
Largest segment | Cartridges |
Fastest growing segment | Vials |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Vials, Prefilled Syringes, Cartridges |
Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Cartridges was the largest segment with a revenue share of 26% in 2024. Horizon Databook has segmented the France fill-finish pharmaceutical contract manufacturing market based on vials, prefilled syringes, cartridges covering the revenue growth of each sub-segment from 2018 to 2030.
The fill-finish pharmaceutical contract manufacturing market in France is a significant part of the country's pharmaceutical industry. According to a report by the French Pharmaceutical Industry Association (Leem), the pharmaceutical industry in France employs over 98,000 people and generates a turnover of around USD 63.7 billion.
The contract manufacturing sector in France is growing, and there are several established and emerging players offering fill-finish services. Some of the leading companies in this space are Recipharm, Fareva, Steris, Novasep, and Aenova.
The market is driven by several factors, including the increasing complexity of drug products, the growing demand for personalized medicine, and the trend of outsourcing manufacturing activities. The COVID-19 pandemic has also highlighted the importance of having a reliable and flexible supply chain for pharmaceutical products, which has led to an increased demand for contract manufacturing services, especially for vaccines and other COVID-related treatments.
Horizon Databook provides a detailed overview of country-level data and insights on the France fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into France fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account